Overview
Pfizer Trading Polska operates in vaccination and oncology, focusing on the development of cancer therapies and products that help prevent infectious diseases. The company also runs a press office, handles adverse event reports, and provides medical and commercial information.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2005-12-31. Active
43 1030 1335 0000 0005 0396 4500- 42 1030 1508 0000 0005 0396 4074
- 83 1030 1508 0000 0005 0396 4015
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| May 29, 2024 | Return of additional payments | |
| Feb 6, 2020 | Call to creditors | |
| Jul 5, 2012 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
217 tenders recorded as contractor: 18 national ($1,095,835) and 199 EU ($1,341,447,110).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 18, 2026 | Dostawa produktów leczniczych, stosowanych w programach lekowych – 39 zadań. | –– | Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie | |
| Sep 7, 2026 | „Dostawa: leków , preparatów do żywienia pozajelitowego i dojelitowego, cytostatyków, leków z programów lekowych, kontrastów, środków opatrunkowych, sprzętu jednorazowego użytku, środków do dezynfekcji, materiałów szewnych i formaliny buforowanej” | –– | Wojewódzki Szpital Specjalistyczny Nr 5 Im. Św. Barbary w Sosnowcu | |
| Aug 28, 2026 | Dostawa leków | $449.9K$449,904 | Uniwersytecki Szpital Kliniczny w Białymstoku |
Public sector contracts
Pfizer Trading Polska is the contractor in 4 public sector contracts, worth PLN 582.98k in total. They were signed with 4 public buyers.
| Public buyer | Value | |
|---|---|---|
| Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych I Administracji w Poznaniu Im. Prof. Ludwika Bierkowskiego | PLN 32,632 | |
| Wojewódzki Szpital Specjalistyczny w Białej Podlaskiej | PLN 44,216 | |
| Międzyleski Szpital Specjalistyczny w Warszawie | PLN 220,148 | |
| Uniwersytecki Szpital Kliniczny w Białymstoku | PLN 285,988 |
Trademarks
Pfizer Trading Polska currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2009.
| Mark | Protected until | |
|---|---|---|
| VETCLUB(word) | – | |
| Pfizer VETCLUB(word) | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, are authorized.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Pfizer Shareholdings Intermediate B.v. | 10,200 | $2,755,267.42 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Roche Polskasp. z o.o. | $799,694,562.77 | roche.pl | ||
| Komtur Polskasp. z o.o. | $424,362,396.43 | komtur.pl | ||
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.com | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| MSD Polska Dystrybucjasp. z o.o. | $341,786,056.16 | msd.pl | ||
| Bristol-Myers Squibb Polskasp. z o.o. | $230,722,737.87 | bms.com | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Roche Diagnostics Polskasp. z o.o. | $199,208,461.57 | roche.pl | ||
| Gilead Sciences Polandsp. z o.o. | $150,844,944.19 | gilead.com | ||
| Phoenix Pharma Polskasp. z o.o. | $140,768,509.34 | phoenixpharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-08-24 | Share capital change (11,050,000.00 PLN → 10,200,000.00 PLN) | |
| 2018-08-14 | Address change (Postępu 17 B, 02-676, Warszawa → Ul. Żwirki I Wigury 16b, 02-092, Warszawa) | |
| 2016-08-30 | PKD change (Removed: 10, 11, 18.13.Z, 20.14.Z, 20.41.Z, 20.42.Z, 20.59.Z, 21.10.Z, 21.20.Z, 26.60.Z, 32.50.Z, 32.99.Z, 46.18.Z, 46.34.B, 46.38.Z, 46.39.Z, 46.45.Z, 46.75.Z, 46.76.Z, 46.90.Z, 49.41.Z, 52.10.A, 52.10.B, 52.21.Z, 52.24.A, 52.24.B, 52.24.C, 58.19.Z, 59.20.Z, 63.12.Z, 63.99.Z, 64.20.Z, 64.92.Z, 64.99.Z, 66.19.Z, 68.32.Z, 69.20.Z, 70.10.Z, 70.21.Z, 70.22.Z, 72.11.Z, 72.19.Z, 73.11.Z, 73.12.A, 73.12.B, 73.12.C, 73.12.D, 73.20.Z, 77.33.Z, 77.39.Z, 77.40.Z, 81.10.Z, 82.30.Z, 85.59.B, 85.60.Z, 86.90.D, 86.90.E; Added: 52, 77.3, 86.9) | |
| 2012-10-01 | Share capital change (13,050,000.00 PLN → 11,050,000.00 PLN) | |
| 2010-10-27 | Address change (Rzymowskiego 34, 02-697, Warszawa → Postępu 17 B, 02-676, Warszawa) |
FAQ
Last updated: 2026-10-14